WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001030348) USE OF SUBSTANCE P ANTAGONISTS FOR INFLUENCING THE CIRCADIAN TIMING SYSTEM
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/030348    International Application No.:    PCT/EP2000/010201
Publication Date: 03.05.2001 International Filing Date: 16.10.2000
Chapter 2 Demand Filed:    19.03.2001    
IPC:
A61K 31/451 (2006.01), A61K 31/454 (2006.01), A61K 31/4545 (2006.01)
Applicants: JANSSEN PHARMACEUTICA N.V. [BE/BE]; De Corte Filip ext- 3834, Patent Department, Turnhoutseweg 30, B-2340 Beerse (BE) (For All Designated States Except US).
DUGOVIC, Christine, Jeanne [FR/US]; (US) (For US Only).
JANSSENS, Frans, Eduard [BE/BE]; (BE) (For US Only)
Inventors: DUGOVIC, Christine, Jeanne; (US).
JANSSENS, Frans, Eduard; (BE)
Agent: QUAGHEBEUR, Luc; Janssen Pharmaceutica N.V., Patent Department - 3547, Turnhoutseweg 30, B-2340 Beerse (BE)
Priority Data:
99203499.1 25.10.1999 EP
Title (EN) USE OF SUBSTANCE P ANTAGONISTS FOR INFLUENCING THE CIRCADIAN TIMING SYSTEM
(FR) UTILISATION D'ANTAGONISTES DE LA SUBSTANCE P DESTINES A INFLUENCER LE RYTHME CIRCADIEN
Abstract: front page image
(EN)The present invention concerns the use of the compounds of formula (I) in the manufacture of medicaments useful for beneficially influencing the circadian timing system or enhancing the sleep efficiency of a mammal, suitably a human being. The compounds of formula (I) are described in full in WO 97/16440, WO 97/14324, WO 97/24350 and WO 97/24356.
(FR)La présente invention concerne l'utilisation de composés de formule (I) dans la fabrication de médicaments servant à influencer positivement le rythme circadien ou à améliorer la qualité du sommeil chez un mammifère, en particulier chez l'homme. Les composés de formule (I) sont entièrement décrits dans WO 97/16440, WO 97/14324, WO 97/24350 et WO 97/24356.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)